EGFR is abnormally activated through various mechanisms, such as receptor overexpression, mutation, ligand-dependent receptor dimerization, and ligand-independent activation, and is associated with the development of a variety of human cancers, so EGFR inhibition is one of the key objectives for cancer chemotherapy [30]. Here, EGFR is linked to cancer.